The Administration’s Orwellian Defense of Importing Foreign Price Controls
BIOtech Now Brian Newell The Trump administration is out with a new blog post defending its plan to adopt foreign price controls […]
Category: News
Greenwood Talks Innovation, Drug Pricing, and the Midterm Elections on ForbesBooks Radio
BIOtech Now Andrew Segerman During the Forbes Healthcare Summit, BIO CEO Jim Greenwood joined Gregg Stebben, host of ForbesBooks Radio, for a […]
Greenwood: Think the Drug-Pricing debate addresses Patient Costs? Think again.
BIOtech Now Andrew Segerman Writing for The Hill, BIO President and CEO Jim Greenwood tackled the drug pricing debate in Washington and […]
Claims of Gene-Edited Twins Met with Criticism and Concern
BIOtech Now Andrew Segerman As the Second International Summit on Human Genome Editing wraps in Hong Kong this week, breaking news dominated much […]
Alzheimer’s Awareness Month: Hope on the Horizon
BIOtech Now Andrew Segerman Did you know that more than 5 million Americans are currently living with Alzheimer’s disease? If that number […]
Another Year, Another Misleading Insurance Company Report
BIOtech Now Brian Newell Once again, Blue Cross Blue Shield is out with a report attempting to stoke fear and confusion about […]
Survey Says: Solutions to Combat Against Antimicrobial Resistance Needed
BIOtech Now Andrew Segerman Writing for The Hill, Dr. Cynthia Sears, president of the Infectious Diseases Society of America (IDSA), discussed the […]
Patient and Health Advocacy Summit: Ensuring Patient Access and Affordability
BIOtech Now Andrew Segerman In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access to the medicines […]
BIO Patient & Health Advocacy Summit Concludes Today
BIOtech Now Theresa Brady Each year BIO brings the patient stakeholder community together for the BIO Patient and Health Advocacy Summit to […]
Patient Advocates Sounding the Alarm Over Fail First
BIOtech Now Andrew Segerman The Centers for Medicare & Medicaid Services (CMS) has reversed a long-standing policy allowing Medicare Advantage plans to […]
Making SMA Newborn Screening a Reality: Collaborating with the Patient Advocacy Community
BIOtech Now BIOtechNOW Editor Each year, roughly 12,500 newborns in the U.S., or one out of every 300 infants, are diagnosed with […]
Watchdog Report Reaffirms Concerns With Fail First
BIOtech Now Brian Newell A new report by the Office of Inspector General at the U.S. Department of Health and Human Services […]
2018 BIO Investor Forum Wraps Up
BIOtech Now Theresa Brady As the stock market continued its volatile swings this week, investors at the BIO Investor Forum—which wrapped up […]
World AMR Congress Keynote Panel to Explore Making “Pull” Incentives a Reality
BIOtech Now BIOtechNOW Editor Here’s a statistic you might not have known: an estimated 700,000 people die each year due to the […]
Drug Importation: Dangerous for Patients, Consumers, and American Communities
BIOtech Now Andrew Segerman Writing for The Hill, Steve Forbes, Forbes Media Chairman and Editor in Chief, delivered a simple message to […]
To Ensure History Does Not Repeat Itself, Get a Flu Shot
BIOtech Now Andrew Segerman The Centers for Disease Control and Prevention (CDC) is out with shocking new data: an estimated 80,000 Americans […]
Trump’s Drug Pricing Blueprint to be Explored at Upcoming Summit
BIOtech Now Theresa Brady In just a few short weeks, BIO will host its annual Patient and Health Advocacy Summit which brings […]
Digital Health Innovation to be Spotlighted at the BIO Investor Forum
BIOtech Now Jessica Torres Is your company trying to expand into “digiceuticals” or digital therapeutics? Are you looking to meet with investors […]
UN Proposals to Weaken IP Will Not Benefit Patients
BIOtech Now George Goodno Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in New York City. […]
The Role – and Value – of Public-Private Partnerships in Preparedness
BIOtech Now BIOtechNOW Editor Nearly twelve years ago, members of the biopharmaceutical supply chain, including BIO, came together in the aftermath of […]